Skip to main content
. 2024 Dec 20;103(51):e40770. doi: 10.1097/MD.0000000000040770

Figure 3.

Figure 3.

The relationship of genetically proxied drug targets with risk of DVT, PE, and VTE using alternative lipid-modifying effect. DVT = deep vein thrombosis, PE = pulmonary embolism, VTE = venous thromboembolism.